BioSpace News Archive

Researchers who tested two commercially available baby monitors are raising serious concerns about the accuracy of these products, which are marketed to parents, but are not regulated by the U.S. Food & Drug Administration (FDA).

Leading professionals in the fields of forensic DNA analysis, genetic genealogy, forensic anthropology and law enforcement will present on the latest research, trends, technologies and ethical issues at the 29th International Symposium on Human Identification (ISHI).

Combining LabChip® GX Touch Nucleic Acid Analyzer and MassARRAY® for Optimized Liquid Biopsy Workflow

Study initiation will prompt a milestone payment from the recently signed deal with Gebro Holding

Imago BioSciences announced today that the Phase 1/2a clinical trial of IMG-7289 for the treatment of high-risk acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS) has fully enrolled at 45 patients.

Dispensaries from Miami to Jacksonville to Provide Patients with FREE Statewide Delivery Service Through 9/1/18

FSD Pharma Inc. is pleased to announce that its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma”), a licensed cannabis producer under the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”), completed the harvest of its first lot of cannabis and successfully passed microbial testing required by Health Canada

Lack of PMN310 binding to amyloid deposits in Alzheimer’s brain tissue may eliminate dose-limiting brain swelling seen with BAN2401 and aducanumab

An innovative technology based on research at the Weizmann Institute of Science

China Biologic Products Holdings, Inc. has received an unsolicited, preliminary non-binding proposal letter from a consortium